What The New York Times didn’t say about a woman ‘caught in the crossfire’ between insurers and drugmakers
Did a pricey cholesterol-lowering drug really reduce deaths, as headlines claim?
No surprise: Repatha reality is messier than initial reports suggested
Whiplash warning! Readers brace for possible neck injury as competing claims on statins hit the headlines
Sponsored content, new cholesterol drugs, and the political process
LDL – Lion King of Surrogate Endpoints – key cholesterol issue this week
What the public doesn’t see about pharma trying to buy influence
Pumping out heart news from the big Heart Association conference